Gynex Corporation FDA Inspection Record

FEI 3001238683 · Inspections, Form 483s, warning letters and import refusals

Gynex Corporation is an FDA-registered facility (FEI 3001238683) located in North Richland Hills, TX, US. RegDataLab tracks 7 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Jan 6, 2020: No Action Indicated (NAI)
Inspections on record
7 (3 VAI, 4 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Recalls as the recalling firm
1, latest Sep 6, 2012

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Jan 6, 2020No Action Indicated (NAI)Lack of or inadequate complaint procedures (21 CFR 820.198(a))
Lack of or inadequate procedures (21 CFR 820.100(a))
Complaints (21 CFR 820.198(a))
Calibration, Inspection, etc. Procedures Lack of or Inadequ (21 CFR 820.72(a))
and 2 more
May 27, 2016Voluntary Action Indicated (VAI)Lack of or inadequate complaint procedures (21 CFR 820.198(a))
Training - Lack of or inadequate procedures (21 CFR 820.25(b))
Lack of or inadequate procedures (21 CFR 820.100(a))
Change records, content (21 CFR 820.40(b))
and 2 more
Apr 25, 2014No Action Indicated (NAI)Lack of procedures, or not maintained (21 CFR 820.40)
Purchasing controls, Lack of or inadequate procedures (21 CFR 820.50)
Sep 21, 2012No Action Indicated (NAI)No citations listed
Jul 20, 2012No Action Indicated (NAI)Design changes - Lack of or Inadequate Procedures (21 CFR 820.30(i))
Process control procedures, Lack of or inadequate procedures (21 CFR 820.70(a))
Jan 21, 2010Voluntary Action Indicated (VAI)Defined areas of adequate size for operations (21 CFR 211.42(c))
Written record of complaint to include findings, follow-up (21 CFR 211.198(b)(2))
Mar 10, 2009Voluntary Action Indicated (VAI)Contract drug products--lack of responsibility (21 CFR 211.22(a))
Written procedures describing in detail (21 CFR 211.122(a))
Complaint Handling Procedure (21 CFR 211.198(a))
Returned drug procedures in writing and followed (21 CFR 211.204)
and 1 more

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Sep 6, 2012Class IIIZ-0008-2013Sterile, single-use, disposable electrosurgical electrode holder. It connects the…
The wrong electrical connector pin was attached to the cord during assembly by the manufacturer. this electrical connector is too big to…

FDA record score

0 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 22, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

3 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAIMay 27, 201610 years or older, so it adds no points0
Inspection classified VAIJan 21, 201010 years or older, so it adds no points0
Inspection classified VAIMar 10, 200910 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 22, 2026Newest record Nov 9, 2026Current
Inspection citationsNov 22, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 22, 2026Newest record Nov 13, 2026Current
Warning letter textNov 22, 2026Newest record Nov 17, 2026Current
Recalls (Enforcement Report)Nov 22, 2026Newest record Nov 18, 2026Current
Form 483s and inspection documentsNov 18, 2026Newest record Nov 17, 2026Current
Import refusalsNov 22, 2026Newest record Nov 12, 2026Current

Reviewing Gynex Corporation as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Gynex Corporation yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Gynex Corporation
Location
North Richland Hills, TX (US)
Source
device

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.